231 related articles for article (PubMed ID: 18594526)
1. FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer.
Nomura S; Yoshitomi H; Takano S; Shida T; Kobayashi S; Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Kato A; Miyazaki M
Br J Cancer; 2008 Jul; 99(2):305-13. PubMed ID: 18594526
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancer.
Matsuda Y; Yoshimura H; Suzuki T; Uchida E; Naito Z; Ishiwata T
Cancer Sci; 2014 Sep; 105(9):1212-9. PubMed ID: 24975163
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.
Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG
Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer.
Cho K; Matsuda Y; Ueda J; Uchida E; Naito Z; Ishiwata T
Int J Oncol; 2012 Apr; 40(4):1040-8. PubMed ID: 22159401
[TBL] [Abstract][Full Text] [Related]
5. Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.
Huijts PE; van Dongen M; de Goeij MC; van Moolenbroek AJ; Blanken F; Vreeswijk MP; de Kruijf EM; Mesker WE; van Zwet EW; Tollenaar RA; Smit VT; van Asperen CJ; Devilee P
Breast Cancer Res; 2011 Jul; 13(4):R72. PubMed ID: 21767389
[TBL] [Abstract][Full Text] [Related]
6. FGFBP1-mediated crosstalk between fibroblasts and pancreatic cancer cells via FGF22/FGFR2 promotes invasion and metastasis of pancreatic cancer.
Zhang Z; Qin Y; Ji S; Xu W; Liu M; Hu Q; Ye Z; Fan G; Yu X; Liu W; Xu X
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):997-1008. PubMed ID: 34117747
[TBL] [Abstract][Full Text] [Related]
7. Collagen regulation of let-7 in pancreatic cancer involves TGF-β1-mediated membrane type 1-matrix metalloproteinase expression.
Dangi-Garimella S; Strouch MJ; Grippo PJ; Bentrem DJ; Munshi HG
Oncogene; 2011 Feb; 30(8):1002-8. PubMed ID: 21057545
[TBL] [Abstract][Full Text] [Related]
8. Congenital heart defects in Fgfr2-IIIb and Fgf10 mutant mice.
Marguerie A; Bajolle F; Zaffran S; Brown NA; Dickson C; Buckingham ME; Kelly RG
Cardiovasc Res; 2006 Jul; 71(1):50-60. PubMed ID: 16687131
[TBL] [Abstract][Full Text] [Related]
9. FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis.
Zhang X; Martinez D; Koledova Z; Qiao G; Streuli CH; Lu P
Development; 2014 Sep; 141(17):3352-62. PubMed ID: 25078648
[TBL] [Abstract][Full Text] [Related]
10. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression.
Koshiba T; Hosotani R; Miyamoto Y; Ida J; Tsuji S; Nakajima S; Kawaguchi M; Kobayashi H; Doi R; Hori T; Fujii N; Imamura M
Clin Cancer Res; 2000 Sep; 6(9):3530-5. PubMed ID: 10999740
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
[TBL] [Abstract][Full Text] [Related]
12. FGF10/FGFR2 Signaling: Therapeutically Targetable Vulnerability in Ligand-responsive Cholangiocarcinoma Cells.
Oeurn K; Jusakul A; Jaidee R; Kukongviriyapan V; Senggunprai L; Prawan A; Kongpetch S
In Vivo; 2023; 37(4):1628-1637. PubMed ID: 37369494
[TBL] [Abstract][Full Text] [Related]
13. FGF8, FGF10 and FGF receptor 2 in foreskin of children with hypospadias: an analysis of immunohistochemical expression patterns and gene transcription.
Haid B; Pechriggl E; Nägele F; Dudas J; Webersinke G; Rammer M; Fritsch H; Oswald J
J Pediatr Urol; 2020 Feb; 16(1):41.e1-41.e10. PubMed ID: 31718875
[TBL] [Abstract][Full Text] [Related]
14. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation.
Ishiwata T; Matsuda Y; Yamamoto T; Uchida E; Korc M; Naito Z
Am J Pathol; 2012 May; 180(5):1928-41. PubMed ID: 22440254
[TBL] [Abstract][Full Text] [Related]
16. Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models.
Zhang H; Hylander BL; LeVea C; Repasky EA; Straubinger RM; Adjei AA; Ma WW
Br J Cancer; 2014 Jan; 110(2):320-9. PubMed ID: 24327018
[TBL] [Abstract][Full Text] [Related]
17. Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway.
Ide T; Kitajima Y; Miyoshi A; Ohtsuka T; Mitsuno M; Ohtaka K; Koga Y; Miyazaki K
Int J Cancer; 2006 Dec; 119(12):2750-9. PubMed ID: 16998831
[TBL] [Abstract][Full Text] [Related]
18. Expression of Fibroblast Growth Factor 10 Is Correlated with Poor Prognosis in Gastric Adenocarcinoma.
Sun Q; Lin P; Zhang J; Li X; Yang L; Huang J; Zhou Z; Liu P; Liu N
Tohoku J Exp Med; 2015 Aug; 236(4):311-8. PubMed ID: 26268776
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor β1 contributes to the invasiveness of pancreatic ductal adenocarcinoma cells through the regulation of CD24 expression.
Kitaura Y; Chikazawa N; Tasaka T; Nakano K; Tanaka M; Onishi H; Katano M
Pancreas; 2011 Oct; 40(7):1034-42. PubMed ID: 21697762
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression.
Chen G; Tian X; Liu Z; Zhou S; Schmidt B; Henne-Bruns D; Bachem M; Kornmann M
Br J Cancer; 2010 Jan; 102(1):188-95. PubMed ID: 19920824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
